Ziltivekimab

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Ziltivekimab
Treatment and conditionWhere it standsTrials
Ziltivekimab for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ziltivekimab for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ziltivekimab for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1